Literature DB >> 14557219

Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.

Allan S Brett1, Wayne Burr, Jamaluddin Moloo.   

Abstract

BACKGROUND: Personalized pharmaceutical marketing to physicians, including the provision of gifts and sponsorship of educational and recreational activities, raises ethical issues. We sought to determine the degree to which physicians regarded common pharmaceutical marketing activities as ethically problematic, and to compare the views of experienced physicians and physicians-in-training.
METHODS: A questionnaire that included 18 scenarios portraying interactions between physicians and the pharmaceutical industry was distributed to residents and faculty members at a US medical school.
RESULTS: Most marketing activities were not thought to pose major ethical problems. Respondents tended to make distinctions about the ethical appropriateness of gifts on the basis of the monetary value and type of gift. Some respondents' views would be in violation of recent professional guidelines that address interactions between physicians and pharmaceutical companies. However, some respondents were troubled by activities that are permitted by professional guidelines. The responses of residents and faculty physicians were similar.
CONCLUSIONS: Despite the recent publicity about ethical problems in relationships between physicians and the pharmaceutical industry, inexperienced and experienced physicians at a single institution continue to have a rather permissive view about a variety of marketing activities.

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  2003        PMID: 14557219     DOI: 10.1001/archinte.163.18.2213

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  24 in total

1.  Effect of drug sample removal on prescribing in a family practice clinic.

Authors:  Daniel M Hartung; David Evans; Dean G Haxby; Dale F Kraemer; Gabriel Andeen; Lyle J Fagnan
Journal:  Ann Fam Med       Date:  2010 Sep-Oct       Impact factor: 5.166

2.  Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures.

Authors:  Bimal H Ashar; Redonda G Miller; Kelly J Getz; Neil R Powe
Journal:  J Gen Intern Med       Date:  2004-11       Impact factor: 5.128

3.  Resident and faculty perceptions of conflict of interest in medical education.

Authors:  Peter Y Watson; Akshay K Khandelwal; Joseph L Musial; John D Buckley
Journal:  J Gen Intern Med       Date:  2005-04       Impact factor: 5.128

4.  Educational governance for the regulation of industry sponsored continuing medical education in interventional and device based therapies.

Authors:  J M Morgan; J Marco; L Stockx; F Zannad
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 5.  Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Authors:  Daniella A Zipkin; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

6.  Gifts and corporate influence in doctor of pharmacy education.

Authors:  Peggy Piascik; Daphne Bernard; Suresh Madhavan; Todd D Sorensen; Steve C Stoner; Tom TenHoeve
Journal:  Am J Pharm Educ       Date:  2007-08-15       Impact factor: 2.047

7.  Physician attitudes toward industry: a view across the specialties.

Authors:  Deborah Korenstein; Salomeh Keyhani; Joseph S Ross
Journal:  Arch Surg       Date:  2010-06

8.  Appropriateness of collaborations between industry and the medical profession: physicians' perceptions.

Authors:  Joseph S Ross; Salomeh Keyhani; Deborah Korenstein
Journal:  Am J Med       Date:  2009-10       Impact factor: 4.965

9.  Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey.

Authors:  Sayaka Saito; Kei Mukohara; Seiji Bito
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

10.  Prescribers and pharmaceutical representatives: why are we still meeting?

Authors:  Melissa A Fischer; Mary Ellen Keough; Joann L Baril; Laura Saccoccio; Kathleen M Mazor; Elissa Ladd; Ann Von Worley; Jerry H Gurwitz
Journal:  J Gen Intern Med       Date:  2009-05-08       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.